Raza Ur Rehman’s Commentary on Fitusiran for the Management of Hemophilia A and B To Be Published
Raza Ur Rehman, Bachelor of Medicine and Surgery at Shaikh Khalifa bin Zayed Al Nahyan Medical and Dental College, shared on LinkedIn:
”I am pleased to share that my commentary article on Fitusiran, a first-in-class RNA interference (RNAi) therapy for the management of Hemophilia A and Hemophilia B, has been accepted for publication in Health Science Reports (Wiley).
This commentary discusses the evolving role of Fitusiran in rebalancing hemostasis and highlights its clinical significance in the current and future landscape of hemophilia management.
I am grateful to the editorial team at Health Science Reports for their efficient handling of the manuscript and the opportunity to contribute to the scientific discourse in this field.”
Stay updated with Hemostasis Today.
-
Jul 2, 2026, 23:11Michael Makris: Join The Cancer Associated Thrombosis Workshop at ISTH 2026
-
Jul 2, 2026, 21:54Rob Maloney: Rare Disease Requires Relational Care
-
Jul 2, 2026, 21:53Quintijn Bonnez: How ADAMTS13 Conformation May Predict Early Relapse and Guide Pre-Emptive Therapy
-
Jul 2, 2026, 21:52Emina Curic: Improving the Understanding of Factor V Leiden in Everyday Clinical Practice
-
Jul 2, 2026, 21:49Lee Peter Bee: The Plastic in Your Blood Is Sabotaging Your Stem Cells
-
Jul 2, 2026, 21:49Atef Ahmed: The Lethal Triad and Damage Control Philosophy
-
Jul 2, 2026, 20:48João L. Carapinha: How Does HYMPAVZI Simplify Hemophilia Management for Patients?
-
Jul 2, 2026, 20:15Celebrationg The 30 Years Anniversary as The Voice of Stroke in Australia – Stroke Foundation
-
Jul 2, 2026, 19:40Minoo Ahmadinejad: Improving the Recognition of Women and Girls With Hemophilia